Tumor necrosis factor-alpha and neuropsychiatric lupus erythematosus: relation to single photon emission computed tomography findings

References

• Boumpass DT, Scott D, Balow JE. Neuropsychiatric lupus: a case for guarded optimism [Editorial]. J Ftheumatol 1993;20:1641–3.
   Google Scholar
• Bonfa E, Golombek S, Kaufman LD, Skelly S, Weissbach H, Brot N, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987;317:265–71.
   PubMed Web of Science ®Google Scholar
• Denburg S, Behmnann S, Carbotte R, Denbur J. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1994;37:369–75.
   PubMedGoogle Scholar
• Toubi E, Khamashta M, Panarra A, Hughes G. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995;99:397–401.
   PubMed Web of Science ®Google Scholar
• Arditi M, Manogue KR, Kaplan M, Yogev R. Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating fac-tor concentrations and severity of bacterial meningitis. J Infect Dis 1990;162:139–47.
   PubMed Web of Science ®Google Scholar
• Hirohata S, Miyamoto T. Elevated levels of interleukin-6 in cere-brospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990;33: 644–9.
   PubMed Web of Science ®Google Scholar
• Alcocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D. Interleukin-1 and interleukin-6 are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activity markers. Lupus 1992;1:111–7.
   PubMed Web of Science ®Google Scholar
• Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum 1992;35:417–22.
   PubMed Web of Science ®Google Scholar
• Blakwill FR. Tumour necrosis factor. Br Med Bull 1989;45:389–400.
   PubMedGoogle Scholar
• Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable MHC Class II associated difference in production of TNF-u: relevance to genetic predisposition to SLE. Proc Natl Acad Sci USA 1990;87:1233–7.
   PubMed Web of Science ®Google Scholar
• Rood MJ, Van Krugten MV, Zanelli E, Van der Lindin MW, Keijsers V, Schreuder GMT, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000;43:129–34.
   PubMed Web of Science ®Google Scholar
• Kovacs JAJ, Murray B, Urowitz Z, Dafina D, Goldman A, Zemen R. The use of SPECT in neuropsychiatric SLE: a pilot study. J Ftheumatol 1995;22:1247–53.
   Google Scholar
• Rubbert A, Marienj HJ, Pirner K, Manger B, Grebmeirr J, Engelhardt A, et al. Single photon emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993;36:1251–62.
   Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R, et al. Validity of the new American College of Ftheumatology criteria for the neuropsychiatric lupus syndrome: a population-based evaluation. Arthritis Rheum 2001;45:419–23.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz M. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;29:981–5.
   Google Scholar
• Jacob CO, McDevitte HO. Tumor necrosis factor-alpha in murine autoimmune lupus nephritis. Nature 1988;331:356–8.
   PubMed Web of Science ®Google Scholar
• Brennan DC, Yui MA, Wuthrich RP, Kelley VE. Tumor necrosis factor and IL-1 in New Zealand black/white mice: enhanced gene expression and acceleration of renal injury. J Immunol 1989;143: 3470–5.
   PubMed Web of Science ®Google Scholar
• Jacob CO, Lewis GD, McDevitte HO. MHC class II-associated variations in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune disease. Immunol Res 1991;10:156–68.
   Google Scholar
• Selmaj K, Reine CS, Cross AH. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991;30:694–700.
   Google Scholar
• Hoffman FM, Hinton DR, Johnson K, Merrile JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989;170: 607–12.
   PubMed Web of Science ®Google Scholar
• Sharieff MK, Hentages R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 1091523:467–72.
   Google Scholar
• Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandburg G, Crayton H, et al. Demyelination occurring during anti-tumor necrosis factor therapy for inflammatory arthritides. Arthritis Rheum 2001;44:2862–9.
   PubMed Web of Science ®Google Scholar
• Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, et al. TNF is a potent tumor necrosis factor cytokine in auto-immune-mediated demyelination. Nat Med 1998;4:78–83.
   PubMed Web of Science ®Google Scholar
• Murry CP, Teppo AM. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32:146–50.
   PubMedGoogle Scholar
• Aderka D, Wysenbeek A, Engelmann H. Correlation between serum levels of soluble TNF-R and disease activity in SLE. Arthri-tis Rheum 1993;36:1111–20.
   Google Scholar
• Meijer C, Huysen V, Smeenk RTJ, Swaak AJG. Profiles of cytokines (TNF-ct and IL-6) and acute-phase proteins (CRP and ct-IAG) related to the disease course in patients with SLE. Lupus 1993;2:359–65.
   PubMed Web of Science ®Google Scholar
• Studnicka-Benke A, Steiner G, Petera P, Smolen JS. Tumor necro-sis factor-alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheum 1996;35:1067–74.
   Google Scholar
• Miret C, Font J, Molina R, Garcia-Carrasco M, FileIla X, Ramos M, et al. Relationship of oncogenes (sFas, Bc1-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythemato-sus. Anticancer Res 2001;21: 3053–9.
   Google Scholar
• Alvarado-de la Barrera C, Alcocer Varela J, Richard-Patin Y, Alarcon-Segovia D, Llorente L. Differential oncogene and TNF-alpha mFtNA expression in bone marrow cells from systemic lupus erythematosus patients. Scand J Immunol 1998;48:551–6.
   Google Scholar
• Gattoron M, Picco P, Barbano G, Stalla F, Sormani MP, Buoncompagni A, et al. Differences in tumor necrosis factor-alpha soluble receptor serum concentration between patients with Henoch-Schonlein purpura and pediatric systemic lupus erythe-matosus. J Ftheumatol 1998;25:361–5.
   Google Scholar
• Robak E, Sysa-Jedrzejewska A, Dziankowska B, Torzecka D, 35. Chojnowski K, Robak T. Association of interferon-gamma, tumor necrosis factor-alpha and interleukin-6 serum levels with systemic 36. lupus erythematosus activity. Arch Immunol Ther Exp 1998;46: 376–80.
   Google Scholar
• Korner H, Ftiminton DS, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD. Critical points of tumor necrosis factor action in 37. central nervous system autoimmune inflammation defined by gene targeting. J Exp Med 1997;189:1585–90.
   Google Scholar
• Svenungsson E, Andersson M, Brundin L, Van Vollenhoven R, 38. Khademi M, Tarkowski A, et al. Increased levels of proinflam-matory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis 2001;60:372–9.
   Google Scholar
• Smolen J. Therapy of systemic lupus erythematosus: a look into the future. Arthritis Res 2002;4 Suppl 3:S25�30.
   Google Scholar
• Falcini F, De Cristofaro MTR, Ermini M, Guarnieri M, Massi G, Olmastroni M, et al. Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study. J Rheumatol 1998;25:583�8.
   Web of Science ®Google Scholar
• Russo R, Gilday D, Laxer RM, Eddy A, Silverman ED. Single photon emission computed tomography scanning in childhood systemic lupus erythematosus. J Rheumatol 1998;25:576�82.
   Google Scholar
• Segal R, Dayan M, Zinger H, Mozes E. Suppression of experimental systemic lupus erythematosus in mice via TNF inhibition by an anti-TNF-alpha monoclonal antibody and by pentoxiphylline. Lupus 2001;10:23�31.
   Web of Science ®Google Scholar